TDK opens its fifth regional headquarters in Asia-Pacific with a new business entity in India
TDK establishes Asia-Pacific Regional Headquarters (APAC RHQ) in India, effective 1 April 2026 APAC RHQ will be operated by TDK Asia-Pacific Pvt. Ltd., a new legal entity to be established in India, and TDK Singapore Pte. Ltd., forming a dual-city...
ENGWE M20 3.0 Officially Launches, Redefining Performance E-Bikes for City Riders and Explorers
NEW YORK, March 2, 2026 /PRNewswire/ -- ENGWE, a global leader in electric mobility, has officially launched the M20 3.0, latest moped-style e-bike built for modern city riders and weekend explorers. Available beginning March 2, the M20 3.0 delivers...
Relativity Unveils Its Fifth Annual AI Visionaries List Ahead of Legalweek 2026
Amplifying the voices guiding the future of AI in the legal profession CHICAGO, March 2, 2026 /PRNewswire/ -- Relativity, a leading legal data intelligence company, today announced its fifth annual list of AI Visionaries. The list honors individuals...
The Sigourney Award-2026 Now Accepting Applications for Psychoanalytic Innovation
International Prize Honors Trailblazing Work Advancing Psychoanalytic Thought and Principles — Cash Award and Global Recognition SAN FRANCISCO, March 2, 2026 /PRNewswire/ -- The Sigourney Award Trust welcomes applications for The Sigourney...
XellSmart Receives Fourth Consecutive US FDA & China NMPA IND Clearance for MSA-P iPSC-derived Cell Therapy
SUZHOU, China, March 2, 2026 /PRNewswire/ -- In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its...
Beko Wins Four iF DESIGN AWARDS 2026, Highlighting Global Leadership in Connected, User-Centered Innovation
129-member panel recognises Beko's refrigerators, digital user experiences and coffee maker interface among world's best ISTANBUL, March 2, 2026 /PRNewswire/ -- Beko, leading global home appliances company, has been honored with four iF DESIGN...
Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair®
PHILADELPHIA, March 2, 2026 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. ("LongBio"), a clinical-stage biotech company focused on discovery and development of biologics targeting allergic and autoimmune diseases, proudly announced positive...
ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy
Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease. SAN FRANCISCO and SHANGHAI, March 2, 2026 /PRNewswire/ -- ReviR Therapeutics, a clinical-stage biotechnology company pioneering AI-driven...